Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Pilocarpus Jaborandii Leaf
Brand Name
Pilocarpus
Generic Name
Pilocarpus Jaborandii Leaf
Active Ingredient
Pilocarpus Jaborandi LeafCategory
Non-Standardized Plant Allergenic Extract [EPC]
Variants
5
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Pilocarpus, you must consult a qualified healthcare professional.
| 9 [hp_C]/9[hp_C] | PELLET | ORAL | 0220-4060 |
| 30 [hp_C]/30[hp_C] | PELLET | ORAL | 0220-4064 |
Detailed information about Pilocarpus
Pilocarpus Jaborandi Leaf is a botanical source of pilocarpine, primarily used as a non-standardized plant allergenic extract and muscarinic agonist to stimulate secretions and manage ocular pressure.
Dosage for Pilocarpus Jaborandi Leaf varies significantly based on the preparation type and the condition being treated. Because this is a non-standardized extract, there is no single 'standard' dose.
The safety and efficacy of Pilocarpus Jaborandi Leaf extracts have not been established in pediatric populations. Its use in children is generally discouraged unless specifically directed by a specialist, such as a pediatric allergist or a physician experienced in botanical medicine. For allergy testing, the dose is minimal and controlled by a healthcare professional.
Because the metabolites are primarily excreted via the kidneys, patients with significant renal impairment (decreased kidney function) may require lower doses or less frequent administration to prevent accumulation of the alkaloids.
Patients with moderate to severe hepatic (liver) impairment should use this substance with extreme caution. The liver is the primary site of metabolic breakdown for Jaborandi alkaloids. A dose reduction of 50% or more may be necessary for patients with cirrhosis or other liver diseases.
Geriatric patients are more susceptible to the side effects of cholinergic stimulation, such as bradycardia (slow heart rate) and increased urinary frequency. Healthcare providers usually start elderly patients at the lowest possible dose.
If you miss a dose of Pilocarpus Jaborandi Leaf, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this significantly increases the risk of cholinergic toxicity.
An overdose of Pilocarpus Jaborandi Leaf can lead to a 'cholinergic crisis.' Symptoms include:
Emergency Measures: If an overdose is suspected, contact emergency services immediately. The standard treatment for cholinergic toxicity is the administration of an anticholinergic agent, such as Atropine, which acts as a physiological antagonist to the Jaborandi alkaloids.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as this could lead to a rebound of symptoms or unexpected side effects.
Due to its potent cholinergic nature, Pilocarpus Jaborandi Leaf frequently causes effects related to the stimulation of the parasympathetic nervous system. These are often dose-dependent:
Pilocarpus Jaborandi Leaf is a powerful pharmacological agent. It should never be used as a self-prescribed supplement. Because it acts on the autonomic nervous system, it can influence heart rate, digestion, and respiratory function. Patients must be screened for underlying conditions that could be exacerbated by cholinergic stimulation.
No FDA black box warnings for Pilocarpus Jaborandi Leaf. However, clinicians treat this substance with the same gravity as prescription muscarinic agonists due to the potential for systemic cholinergic crisis.
Pilocarpus Jaborandi Leaf must NEVER be used in the following circumstances:
FDA Pregnancy Category C (Historical): There are no adequate and well-controlled studies of Pilocarpus Jaborandi Leaf in pregnant women. Animal studies have shown that cholinergic stimulation can affect uterine tone. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Use during the third trimester is particularly sensitive due to the risk of inducing premature uterine contractions.
It is unknown whether the alkaloids from Pilocarpus Jaborandi Leaf are excreted in human milk. However, many alkaloids do pass into breast milk. Because of the potential for serious adverse reactions in nursing infants (such as diarrhea, excessive sweating, or heart rate changes), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients have not been established. The use of this substance in children is rare and must be managed by a specialist. Children are more sensitive to the systemic effects of cholinergic stimulation and are at higher risk for respiratory complications.
Pilocarpus Jaborandi Leaf acts as a direct-acting cholinergic parasympathomimetic agent. Its primary active constituent, pilocarpine, is a muscarinic agonist. It binds to muscarinic acetylcholine receptors, which are G-protein coupled receptors.
Common questions about Pilocarpus
Pilocarpus Jaborandi Leaf is primarily used for its ability to stimulate secretions in the body, most notably saliva and sweat. In clinical settings, it is often utilized to treat xerostomia (dry mouth) resulting from radiation therapy or Sjögren's syndrome. It also serves as a source for pilocarpine, which is used in eye drops to treat glaucoma by reducing intraocular pressure. Additionally, it is used as a non-standardized allergenic extract for diagnostic skin testing. Some practitioners also use it in homeopathic preparations for various ailments involving fluid imbalance. Always consult a healthcare provider before using any form of Jaborandi.
The most frequent side effects are related to over-stimulation of the parasympathetic nervous system, with excessive sweating (diaphoresis) being the most reported. Patients also commonly experience increased salivation, a frequent urge to urinate, and mild stomach cramps or nausea. Because it constricts the pupils, many people notice blurred vision, especially in low-light environments. Chills and a runny nose are also frequently observed shortly after taking the extract. Most of these effects are dose-dependent and subside as the medication is cleared from the system. If these symptoms become severe, medical advice should be sought immediately.
It is generally advised to avoid alcohol while taking Pilocarpus Jaborandi Leaf or its derivatives. Alcohol can exacerbate many of the drug's side effects, such as dizziness, lightheadedness, and gastrointestinal irritation. Furthermore, both Jaborandi and alcohol can contribute to dehydration—Jaborandi through excessive sweating and alcohol through its diuretic effects. This combination can lead to electrolyte imbalances and increased cardiovascular stress. If you choose to consume alcohol, it should be in very limited quantities and only after discussing the risks with your doctor. Maintaining high water intake is crucial if any alcohol is consumed.
Pilocarpus Jaborandi Leaf is not considered established as safe during pregnancy and is historically classified in Pregnancy Category C. This means that animal studies have shown potential risks, or there is a lack of adequate human data. The cholinergic effects of the drug could potentially stimulate uterine contractions, posing a risk of preterm labor. It should only be used if a physician determines that the benefits to the mother significantly outweigh the potential risks to the fetus. Pregnant women should always disclose their pregnancy status before starting any botanical or cholinergic treatment. Alternative treatments for dry mouth or glaucoma are often preferred during pregnancy.
When taken orally as an extract or tincture, the effects of Pilocarpus Jaborandi Leaf usually begin within 20 minutes. The peak effect, such as the maximum increase in saliva production, typically occurs about one hour after administration. The duration of these effects is relatively short, usually lasting between 3 and 5 hours, which is why the medication is often dosed multiple times per day. For allergy testing, a skin reaction usually develops within 15 to 30 minutes of application. If you do not notice an improvement in symptoms within the expected timeframe, do not increase the dose without consulting your healthcare provider.
While Pilocarpus Jaborandi Leaf is not known to be addictive, you should not stop taking it suddenly if you have been using it for a prolonged period. Abrupt discontinuation can cause a 'rebound' effect, where the glands that were being stimulated suddenly become underactive, leading to severe dry mouth or dry eyes. This can be quite uncomfortable and may exacerbate the underlying condition being treated. Your doctor will typically recommend a gradual reduction in dose to allow your body to adjust. Always follow a medically supervised tapering schedule when ending treatment. If you experience any new or worsening symptoms during this time, contact your provider.
If you miss a dose, you should take it as soon as you realize it, provided it is not almost time for your next dose. If the next dose is only a few hours away, it is safer to skip the missed dose entirely and resume your normal schedule. Never take two doses at once to make up for a missed one, as this significantly increases the risk of a cholinergic overdose. Overdosing can lead to serious symptoms like heart rate changes and respiratory distress. Setting a daily alarm can help you maintain a consistent dosing schedule. If you frequently miss doses, discuss alternative treatment options with your healthcare provider.
There is no clinical evidence to suggest that Pilocarpus Jaborandi Leaf causes weight gain. In fact, because it increases metabolic processes like sweating and salivation, it does not typically contribute to fat accumulation. However, some patients might experience temporary changes in weight due to fluid loss from excessive sweating or diarrhea if the dose is too high. If you notice significant or rapid weight changes while taking this medication, it is likely due to another factor or an underlying health condition. You should discuss any unexpected weight changes with your doctor to determine the cause. Maintaining a balanced diet and proper hydration is always recommended.
Pilocarpus Jaborandi Leaf has many potential drug interactions, particularly with medications that affect the heart or the nervous system. It should not be taken with anticholinergic drugs like atropine, as they will cancel each other out. It can also be dangerous when combined with beta-blockers, as this can cause the heart rate to drop to unsafe levels. Many over-the-counter allergy and sleep medications have hidden anticholinergic effects that can reduce the efficacy of Jaborandi. Always provide your doctor with a complete list of all prescriptions, supplements, and herbal remedies you are using. This allows for a thorough screening of potential interactions.
Pilocarpus Jaborandi Leaf itself is a botanical substance and is not 'branded' in the same way as synthetic drugs, though various manufacturers produce standardized and non-standardized extracts. The primary active alkaloid derived from it, pilocarpine, is widely available as a generic prescription medication in both tablet and eye-drop forms. Generic versions are typically much more affordable than brand-name equivalents and are required by the FDA to be bioequivalent. If you are using the leaf extract for homeopathic purposes, these are available under various labels but are not classified as generics. Check with your pharmacist to see which version is most appropriate for your needs.
> Warning: Stop taking Pilocarpus Jaborandi Leaf and call your doctor immediately if you experience any of these serious symptoms:
Prolonged use of Pilocarpus Jaborandi Leaf extracts may lead to 'cholinergic tolerance,' where the body becomes less responsive to the drug, requiring higher doses for the same effect. There is also a risk of chronic electrolyte imbalances if the patient does not adequately compensate for the fluid lost through sweat and increased urination. Long-term ocular use of Jaborandi derivatives has been associated with the development of cataracts or changes in the lens of the eye.
No FDA black box warnings specifically exist for the raw Pilocarpus Jaborandi Leaf extract; however, the purified alkaloid pilocarpine carries significant warnings regarding its use in patients with iritis (eye inflammation) and those with a history of retinal detachment. Because the leaf contains these alkaloids, the same precautions should be applied. Patients with narrow-angle glaucoma are at risk of an acute attack if the drug is used improperly.
Report any unusual symptoms to your healthcare provider. Even mild side effects should be discussed, as they may indicate a need for dose adjustment or a change in the frequency of administration.
If you are taking Pilocarpus Jaborandi Leaf long-term, your doctor may require the following:
This medication causes miosis, which reduces the amount of light entering the eye. This can significantly impair vision in dim light or at night. Do not drive or operate heavy machinery at night or in poorly lit environments until you know how this medication affects your vision.
Alcohol should be avoided or used with extreme caution. Alcohol can increase the risk of dizziness and dehydration, both of which are potential side effects of Pilocarpus Jaborandi Leaf. Furthermore, alcohol may irritate the stomach lining, compounding the GI side effects of the drug.
Do not stop taking this medication abruptly if you have been using it for a long period. While it does not have a traditional 'withdrawal syndrome,' a sudden cessation can lead to a 'rebound' effect where secretions (saliva, tears) decrease significantly, causing acute discomfort. Your doctor will provide a tapering schedule if you need to stop the medication.
> Important: Discuss all your medical conditions, especially any history of heart, lung, or eye disease, with your healthcare provider before starting Pilocarpus Jaborandi Leaf.
Pilocarpus Jaborandi Leaf is not known to significantly interfere with common blood chemistry panels, but its physiological effects may influence:
For each major interaction, the mechanism usually involves pharmacodynamic antagonism (drugs fighting for the same receptor) or pharmacodynamic synergism (drugs hitting the same system too hard). The clinical consequence is either a loss of symptom control or an increase in toxic side effects.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines and sleep aids, as many of these have hidden anticholinergic properties.
Conditions requiring a careful risk-benefit analysis by a physician:
Patients who are allergic to other members of the Rutaceae family (which includes citrus fruits like lemons, oranges, and grapefruit) should be cautious. While the allergens are different, there is a documented risk of cross-reactivity with botanical extracts from the same plant family.
> Important: Your healthcare provider will evaluate your complete medical history, including any minor respiratory or digestive issues, before prescribing Pilocarpus Jaborandi Leaf.
Clinical studies of pilocarpine-containing products have shown that elderly patients may be at increased risk of certain side effects:
In patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the excretion of Jaborandi metabolites is significantly slowed. These patients should be monitored for signs of systemic toxicity, and dosing intervals may need to be extended.
For patients with Child-Pugh Class B or C hepatic impairment, the starting dose should be reduced by at least 50%. The liver's reduced capacity to clear the alkaloids can lead to prolonged and intensified effects.
> Important: Special populations require individualized medical assessment. Always inform your provider if you are planning a pregnancy or have chronic kidney or liver issues.
| Parameter | Value |
|---|---|
| Bioavailability | ~50-80% (Alkaloid dependent) |
| Protein Binding | 5% to 15% |
| Half-life | 0.76 to 1.35 hours |
| Tmax | 1 hour |
| Metabolism | Hepatic (Hydrolysis to pilocarpic acid) |
| Excretion | Renal (80-90% as metabolites) |
Pilocarpus Jaborandi Leaf is classified as a Natural Product / Parasympathomimetic. It is the botanical precursor to modern ophthalmic and oral cholinergic drugs. Within the EPC (Established Pharmacologic Class), it is a Non-Standardized Plant Allergenic Extract, though its therapeutic utility is primarily muscarinic.